Psychometric validation of a clinician‐reported clinical severity assessment in STXBP1 ‐related disorder
Year: 2026
Type: article
Abstract: Aim To adapt a validated clinician‐reported measure from CDKL5 deficiency disorder for use in STXBP1 ‐related disorders and evaluate the psychometric properties of the resulting STXBP1 Clinical Severity Assessment (S‐CSA). Method In this multicenter, prospective, natural history study, the S‐CSA was adapted from the CDKL5 Clinical Severity Assessment through expert consensus sessions with STXBP1 clinicians. Revisions addressed gaps in the motor and vision domains, adding tremor and vision items. The measure was administered to 123 individuals with STXBP1 ‐related disorders (50% males, median age 7 years 8 months). Psychometric evaluation included confirmatory factor analysis, internal consistency, composite reliability, average variance extracted, and distinctiveness, compared with recommended thresholds. Results Analyses supported a three‐domain structure (motor, communication, vision) with factor loadings greater than 0.5 and strong internal consistency (Cronbach's alpha >0.7; composite reliability >0.88). Model fit and variance metrics met the recommended standards, and domains demonstrated distinctiveness. No ceiling or floor effects were observed. Minimal skew was seen in the motor (0.34) and communication (−0.16) domains; positive skew in vision (2.2) was observed, identifying patients with and without cortical visual impairment. Interpretation The S‐CSA demonstrates strong validity and reliability in STXBP1 ‐related disorders and may show utility in clinical trials for STXBP1 ‐related disorders and potentially other severe developmental and epileptic encephalopathies.
DOI: 10.1111/dmcn.70570
Authors: Megan Abbott, Peter Jacoby, Katie Angione, Tim A. Benke, Hsiao-Tuan Chao, JoeyLynn Coyne, Kristin Cunningham, Danielle deCampo, Jenny Downs, Jim Goss, Zachary Grinspan, Morgan Jolliffe, Juliet Knowles, Eric Marsh, Jillian L. McKee, Andrea Miele, Samuel R. Pierce, Sarah M. Ruggiero, Charlene Son Rigby, Megan Stringfellow, Sarah Tefft, Katherine Xiong, Ingo Helbig, Scott Demarest
Institutions: Children's Hospital Colorado, University of Colorado Anschutz, University of Colorado Denver, The Kids Research Institute Australia, The University of Western Australia, Baylor College of Medicine, Texas Children's Hospital, Children's Hospital of Philadelphia, University of Pennsylvania, Weill Cornell Medicine, Stanford Medicine, Stanford University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Simons Foundation, American Epilepsy Society, American Brain Foundation, American Academy of Neurology, Texas Children's Hospital, Children's Hospital Colorado, Dravet Syndrome Foundation, Pediatric Epilepsy Research Foundation, International Foundation for CDKL5 Research, Epilepsy Society, National Institutes of Health, National Institute of Neurological Disorders and Stroke
Awards: Subgroup delineation in genetic epilepsies and developmental brain disorders, NS-PEACE Neonatal Seizures -Predicting Epilepsy and Assessing Comparative Effectiveness, A computational phenotyping approach to characterize neurogenetic disorders, Outcome measures and quantitative EEG biomarkers in SYNGAP1-related disorders
OpenAlex ID: W7162770714
